story of the week
Utidelone Plus Capecitabine vs Capecitabine Alone for Heavily Pretreated Metastatic Breast Cancer Refractory to Anthracyclines and Taxanes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology